SARAH KOVARIK: Open Payments
NPI 1285099374 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 23 payments from 13 companies in 2025. Trend: 2023 $273 · 2024 $396 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $84 |
| UCB, Inc. | 2 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Galderma Laboratories, L.P. | 3 | $53 |
| LEO Pharma Inc. | 2 | $42 |
| Organon LLC | 2 | $36 |
| Lilly USA, LLC | 1 | $23 |
| Botanix SB Inc | 1 | $22 |
| Amgen Inc. | 1 | $21 |
Products named: Bimzelx, DUPIXENT, ADBRY, SKYRIZI, Rhapsido, COSENTYX, VTAMA, BOTOX.
Industry payments across IL — which companies pay providers there.
